(Q35914938)

11 August 2017

1 reference

title

Regulation of immune responses by CD1d-restricted natural killer T cells (English)

1 reference

11 August 2017

1

Luc Van Kaer

1 reference

11 August 2017

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

30

1 reference

11 August 2017

2

1 reference

11 August 2017

139-153

1 reference

https://scigraph.springernature.com/pub.10.1385/ir:30:2:139

11 August 2017

0 references

cites work

CD1d-Restricted NKT Cells: An Interstrain Comparison

1 reference

12 December 2020

Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells

1 reference

12 December 2020

Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production

1 reference

12 December 2020

The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs

1 reference

12 December 2020

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

1 reference

12 December 2020

Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes

1 reference

12 December 2020

Interleukin-4-producing CD4+ NK1.1+ TCR alpha/beta intermediate liver lymphocytes are down-regulated by Listeria monocytogenes

1 reference

12 December 2020

Immunotherapy with ligands of natural killer T cells

1 reference

12 December 2020

NK1.1+ CD4+ T cells lose NK1.1 expression upon in vitro activation.

1 reference

12 December 2020

Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency

1 reference

12 December 2020

CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes

1 reference

12 December 2020

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors

1 reference

12 December 2020

A subset of CD4+ thymocytes selected by MHC class I molecules

1 reference

12 December 2020

Natural killer T cells as targets for therapeutic intervention in autoimmune diseases.

1 reference

12 December 2020

NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen

1 reference

12 December 2020

Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected].

1 reference

12 December 2020

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

1 reference

12 December 2020

Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.

1 reference

12 December 2020

Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype

1 reference

12 December 2020

Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity

1 reference

12 December 2020

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

1 reference

12 December 2020

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

1 reference

12 December 2020

Liver NKT cells: an account of heterogeneity

1 reference

12 December 2020

Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.

1 reference

12 December 2020

Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma

1 reference

12 December 2020

The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.

1 reference

12 December 2020

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

12 December 2020

CD1-restricted antigen presentation: an oily matter

1 reference

12 December 2020

Repeated -Galactosylceramide Administration Results in Expansion of NK T Cells and Alleviates Inflammatory Dermatitis in MRL-lpr/lpr Mice

1 reference

12 December 2020

Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4

1 reference

12 December 2020

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

12 December 2020

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

1 reference

12 December 2020

In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers

1 reference

12 December 2020

The NOD mouse model of type 1 diabetes: as good as it gets?

1 reference

12 December 2020

Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse

1 reference

12 December 2020

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

1 reference

12 December 2020

CD1 recognition by mouse NK1+ T lymphocytes

1 reference

12 December 2020

The Paradox of Immune Molecular Recognition of α-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for αβ TCRs

1 reference

12 December 2020

Antigen presentation by major histocompatibility complex class I-B molecules

1 reference

12 December 2020

Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove

1 reference

12 December 2020

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

1 reference

12 December 2020

The unconventional lifestyle of NKT cells

1 reference

12 December 2020

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

1 reference

12 December 2020

alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

1 reference

12 December 2020

Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells

1 reference

12 December 2020

The innate immune response differs in primary and secondary Salmonella infection.

1 reference

12 December 2020

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

12 December 2020

Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice.

1 reference

12 December 2020

Assessment of animal models for MS and demyelinating disease in the design of rational therapy

1 reference

12 December 2020

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

On the dynamics of TCR:CD3 complex cell surface expression and downmodulation

1 reference

12 December 2020

Tolerance to islet autoantigens in type 1 diabetes

1 reference

12 December 2020

CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

1 reference

12 December 2020

Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells

1 reference

12 December 2020

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

1 reference

12 December 2020

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

12 December 2020

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids

1 reference

12 December 2020

Rapid Death and Regeneration of NKT Cells in Anti-CD3ε- or IL-12-Treated Mice

1 reference

12 December 2020

CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4

1 reference

12 December 2020

Genetic models for CNS inflammation

1 reference

12 December 2020

Redirecting Th1 and Th2 responses in autoimmune disease.

1 reference

12 December 2020

NKT cells: facts, functions and fallacies.

1 reference

12 December 2020

The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion

1 reference

12 December 2020

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

12 December 2020

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

1 reference

12 December 2020

Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells

1 reference

12 December 2020

Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.

1 reference

12 December 2020

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis

1 reference

12 December 2020

CD1d and natural T cells: how their properties jump-start the immune system

1 reference

12 December 2020

Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.

1 reference

12 December 2020

Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:30:2:139

1 reference

PubMed ID

15477656

Dimensions Publication ID

11 August 2017

0 references

1 reference

PubMed ID

15477656